domains/health/Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening.md

@@ -23,6 +23,12 @@ Devoted was built from scratch on the Orinoco platform — a unified AI-native o
 
 Since [[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]], UnitedHealth's $9 billion annual technology spend directed at optimizing existing infrastructure (consolidating 18 EMRs, AI scribing within legacy workflows) rather than rebuilding around prevention is textbook proxy inertia. The margin from coding arbitrage rationally prevents pursuit of the purpose-built alternative.
 
+
+### Additional Evidence (extend)
+*Source: [[2025-07-24-kff-medicare-advantage-2025-enrollment-update]] | Added: 2026-03-11 | Extractor: anthropic/claude-sonnet-4.5*
+
+The broader MA market context shows UnitedHealth gained 505K members in 2025 while Humana lost 297K, demonstrating that market share is consolidating toward the largest player (UHG now 29% market share, 9.9M enrollees) rather than fragmenting to purpose-built entrants. UHG + Humana together control 46% of all MA enrollment, with 815 counties (26% of all counties) showing 75%+ concentration in these two organizations. This suggests Devoted's 121% growth may be from a small base in a market where scale and acquisition-based integration still dominate despite CMS tightening. The data indicates that while purpose-built technology may be growing faster percentage-wise, the absolute market consolidation trend favors incumbents with existing scale and risk adjustment infrastructure.
+
 ---
 
 Relevant Notes:

domains/health/chronic-condition-special-needs-plans-grew-71-percent-in-2025-indicating-explosive-demand-for-disease-management-infrastructure.md

@@ -0,0 +1,39 @@
+---
+type: claim
+domain: health
+description: "C-SNPs grew 71% year-over-year in 2025 while overall SNP enrollment reached 21% of MA, indicating chronic disease management is the fastest-growing segment"
+confidence: likely
+source: "KFF Medicare Advantage Enrollment Update 2025"
+created: 2025-07-24
+depends_on: []
+challenged_by: []
+secondary_domains: ["teleological-economics"]
+---
+
+# Chronic condition special needs plans grew 71 percent in 2025 indicating explosive demand for disease management infrastructure
+
+Chronic Condition Special Needs Plans (C-SNPs) experienced 71% growth between 2024 and 2025, making them the fastest-growing segment of the Medicare Advantage market. C-SNPs now represent 1.2M enrollees (16% of all SNP enrollment), while total Special Needs Plan enrollment reached 7.3M (21% of all MA enrollment, up from 14% in 2020).
+
+This explosive growth in C-SNPs specifically—rather than D-SNPs (dual-eligible) or I-SNPs (institutional)—signals that chronic disease management is becoming the dominant operational challenge and business opportunity in Medicare. The growth rate far exceeds overall MA growth (4%) and even total SNP growth, suggesting that plans are actively building or acquiring chronic condition management capabilities.
+
+The timing coincides with the metabolic disease epidemic and the GLP-1 therapeutic category launch, suggesting C-SNP growth is driven by the need for infrastructure to manage chronic conditions at scale. Plans that can effectively manage diabetes, cardiovascular disease, and obesity through coordinated care models are capturing enrollment growth. However, this represents disease management optimization rather than prevention-first economics, as evidenced by the parallel growth in the federal overpayment gap despite majority MA enrollment.
+
+## Evidence
+
+- C-SNP enrollment: 1.2M (16% of SNP enrollment)
+- C-SNP growth rate 2024-2025: 71%
+- Total SNP enrollment: 7.3M (21% of all MA enrollment, up from 14% in 2020)
+- D-SNP enrollment: 6.1M (83% of SNPs)
+- I-SNP enrollment: 115K (2% of SNPs)
+- Overall MA growth rate 2024-2025: 4%
+- Growth rate differential: C-SNP growth (71%) is 17.75x overall MA growth (4%)
+
+---
+
+Relevant Notes:
+- [[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035.md]]
+- [[Big Food companies engineer addictive products by hacking evolutionary reward pathways creating a noncommunicable disease epidemic more deadly than the famines specialization eliminated.md]]
+- [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md]]
+
+Topics:
+- [[domains/health/_map]]

domains/health/medicare-advantage-crossed-majority-enrollment-in-2023-marking-structural-shift-from-traditional-medicare-as-default-program.md

@@ -0,0 +1,34 @@
+---
+type: claim
+domain: health
+description: "MA enrollment reaching 51% in 2023 and 54% by 2025 represents a structural transformation where managed care becomes the dominant Medicare delivery model"
+confidence: proven
+source: "KFF Medicare Advantage Enrollment Update 2025"
+created: 2025-07-24
+depends_on: []
+challenged_by: []
+---
+
+# Medicare Advantage crossed majority enrollment in 2023 marking structural shift from traditional Medicare as default program
+
+Medicare Advantage enrollment crossed the 50% threshold in 2023 (30.8M enrollees, 51% penetration) and reached 54% by 2025 (34.1M enrollees). This represents a structural inflection point where managed care becomes the dominant Medicare delivery model rather than an alternative option. Traditional fee-for-service Medicare is now the minority program.
+
+The trajectory shows consistent acceleration: from 19% penetration in 2007 (7.6M) to 25% in 2010 (10.8M), 32% in 2015 (16.2M), 42% in 2020 (23.8M), and 54% by 2025. CBO projects 64% penetration by 2034, suggesting this transition will continue.
+
+The 2024-2025 growth rate of 4% (1.3M additional enrollees) demonstrates sustained momentum even as the program reaches majority scale. This is not a temporary trend but a fundamental restructuring of how Medicare beneficiaries receive care.
+
+## Evidence
+
+- KFF data shows MA enrollment grew from 7.6M (19%) in 2007 to 34.1M (54%) in 2025
+- First crossed 50% threshold in 2023 with 30.8M enrollees (51% penetration)
+- CBO projects continued growth to 64% penetration by 2034
+- Growth rate remained at 4% (1.3M enrollees) between 2024-2025 despite majority-scale enrollment
+
+---
+
+Relevant Notes:
+- [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md]]
+- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md]]
+
+Topics:
+- [[domains/health/_map]]

domains/health/medicare-advantage-market-is-oligopolistic-with-unitedhealth-and-humana-controlling-46-percent-despite-nominal-plan-choice.md

@@ -0,0 +1,38 @@
+---
+type: claim
+domain: health
+description: "Two parent organizations control nearly half of all MA enrollment with 815 counties showing 75%+ concentration despite beneficiaries having 9+ plan options on average"
+confidence: proven
+source: "KFF Medicare Advantage Enrollment Update 2025"
+created: 2025-07-24
+depends_on: []
+challenged_by: []
+---
+
+# Medicare Advantage market is oligopolistic with UnitedHealth and Humana controlling 46 percent despite nominal plan choice
+
+The Medicare Advantage market exhibits oligopolistic concentration despite the appearance of competitive choice. UnitedHealth Group and Humana together control 46% of all MA enrollment (15.6M of 34.1M enrollees), with UHG alone holding 29% market share (9.9M) and Humana 17% (5.7M).
+
+This concentration is even more extreme at the county level: 815 counties (26% of all counties) have 75% or more of their MA enrollment concentrated in just these two organizations. This means that in over a quarter of US counties, three-quarters of MA beneficiaries are enrolled with either UnitedHealth or Humana.
+
+The concentration is intensifying rather than diversifying. In 2025, Humana lost 297K members while UHG gained 505K, suggesting market share is consolidating toward the largest player rather than fragmenting across competitors.
+
+This oligopoly persists despite nominal choice: the average beneficiary has 9 plan options, and 36% of beneficiaries have 10+ plan options. The presence of multiple plan offerings does not translate to competitive market dynamics when those plans are owned by two dominant parent organizations.
+
+## Evidence
+
+- UnitedHealth Group: 9.9M enrollees (29% market share)
+- Humana: 5.7M enrollees (17% market share)
+- Combined UHG + Humana: 15.6M enrollees (46% of total MA enrollment)
+- 815 counties (26% of all counties) have 75%+ enrollment concentration in UHG & Humana
+- 2025 market dynamics: Humana lost 297K members while UHG gained 505K
+- Average beneficiary has 9 plan options; 36% have 10+ options
+
+---
+
+Relevant Notes:
+- [[Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening.md]]
+- [[CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring.md]]
+
+Topics:
+- [[domains/health/_map]]

domains/health/medicare-advantage-overpayment-gap-grew-4-7x-while-enrollment-doubled-showing-scale-worsens-rather-than-improves-efficiency.md

@@ -0,0 +1,40 @@
+---
+type: claim
+domain: health
+description: "Federal spending premium over FFS equivalent grew from $18B in 2015 to $84B in 2025 while enrollment only doubled demonstrating that MA scale increases rather than reduces overpayment"
+confidence: proven
+source: "KFF Medicare Advantage Enrollment Update 2025"
+created: 2025-07-24
+depends_on: []
+challenged_by: []
+secondary_domains: ["teleological-economics"]
+---
+
+# Medicare Advantage overpayment gap grew 4.7x while enrollment doubled showing scale worsens rather than improves efficiency
+
+The federal spending premium for Medicare Advantage over traditional fee-for-service Medicare grew from $18B in 2015 to $84B in 2025—a 4.7x increase—while enrollment only doubled from ~16M to 34M over the same period. This demonstrates that scale is making the overpayment problem worse, not better.
+
+In 2025, Medicare pays 20% more per MA enrollee than the equivalent cost in traditional FFS Medicare, totaling $84B in excess federal spending. This per-person premium has remained structurally elevated even as the program has grown to majority-enrollment scale.
+
+The trajectory contradicts the theoretical efficiency gains that managed care was supposed to deliver at scale. If MA plans were achieving operational efficiencies through care coordination and prevention, the per-person spending gap should narrow as enrollment grows. Instead, the absolute overpayment has grown faster than enrollment, suggesting that MA plans are extracting value through risk score optimization and favorable selection rather than through genuine care delivery improvements.
+
+This spending gap acceleration is particularly significant given that MA crossed 50% enrollment in 2023. The program is no longer a niche alternative—it's the dominant Medicare delivery model—yet it continues to cost substantially more per beneficiary than traditional Medicare.
+
+## Evidence
+
+- 2015 MA overpayment: $18B (when ~16M enrolled, ~32% penetration)
+- 2025 MA overpayment: $84B (when 34.1M enrolled, 54% penetration)
+- Overpayment growth: 4.7x
+- Enrollment growth: 2.1x
+- 2025 per-person premium: 20% above FFS equivalent
+- Overpayment growth rate (4.7x) exceeds enrollment growth rate (2.1x) by 2.24x
+
+---
+
+Relevant Notes:
+- [[CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring.md]]
+- [[Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening.md]]
+- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md]]
+
+Topics:
+- [[domains/health/_map]]

domains/health/the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md

@@ -285,6 +285,12 @@ Healthcare is the clearest case study for TeleoHumanity's thesis: purpose-driven
 
 PACE provides the most comprehensive real-world test of the prevention-first attractor model: 100% capitation, fully integrated medical/social/psychiatric care, continuous monitoring of a nursing-home-eligible population, and 8-year longitudinal data (2006-2011). Yet the ASPE/HHS evaluation reveals that PACE does NOT reduce total costs—Medicare capitation rates are equivalent to FFS overall (with lower costs only in the first 6 months post-enrollment), while Medicaid costs are significantly HIGHER under PACE. The value is in restructuring care (community vs. institution, chronic vs. acute) and quality improvements (significantly lower nursing home utilization across all measures, some evidence of lower mortality), not in cost savings. This directly challenges the assumption that prevention-first, integrated care inherently 'profits from health' in an economic sense. The 'flywheel' may be clinical and social value, not financial ROI. If the attractor state requires economic efficiency to be sustainable, PACE suggests it may not be achievable through care integration alone.
 
+
+### Additional Evidence (challenge)
+*Source: [[2025-07-24-kff-medicare-advantage-2025-enrollment-update]] | Added: 2026-03-11 | Extractor: anthropic/claude-sonnet-4.5*
+
+Medicare Advantage enrollment reached 54% penetration by 2025 (34.1M enrollees) with CBO projecting 64% by 2034, yet the federal overpayment gap grew from $18B in 2015 to $84B in 2025—a 4.7x increase while enrollment only doubled. This suggests that the dominant managed care model is not converging toward prevention-first economics but rather extracting value through risk score optimization. The C-SNP segment (chronic condition management) is growing at 71% annually, indicating the system is building infrastructure for disease management at scale rather than prevention. The attractor state may be disease management optimization rather than health creation. KFF data shows that despite MA becoming the majority delivery model, per-person spending remains 20% above FFS equivalent, contradicting the hypothesis that aligned payment and continuous monitoring create efficiency gains at scale.
+
 ---
 
 Relevant Notes:

domains/health/value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md

@@ -23,6 +23,12 @@ The Making Care Primary model's termination in June 2025 (after just 12 months,
 
 PACE represents the extreme end of value-based care alignment—100% capitation with full financial risk for a nursing-home-eligible population. The ASPE/HHS evaluation shows that even under complete payment alignment, PACE does not reduce total costs but redistributes them (lower Medicare acute costs in early months, higher Medicaid chronic costs overall). This suggests that the 'payment boundary' stall may not be primarily a problem of insufficient risk-bearing. Rather, the economic case for value-based care may rest on quality/preference improvements rather than cost reduction. PACE's 'stall' is not at the payment boundary—it's at the cost-savings promise. The implication: value-based care may require a different success metric (outcome quality, institutionalization avoidance, mortality reduction) than the current cost-reduction narrative assumes.
 
+
+### Additional Evidence (confirm)
+*Source: [[2025-07-24-kff-medicare-advantage-2025-enrollment-update]] | Added: 2026-03-11 | Extractor: anthropic/claude-sonnet-4.5*
+
+Medicare Advantage now represents 54% of all Medicare enrollment (34.1M beneficiaries) yet the federal overpayment gap is $84B in 2025 (20% per-person premium over FFS), up from $18B in 2015. Despite MA being nominally 'value-based' and representing majority enrollment, the spending gap has grown 4.7x while enrollment only doubled. This confirms that touching value metrics (which MA plans do through risk adjustment and quality bonuses) does not translate to actual cost reduction or risk-bearing when the payment structure still rewards volume and favorable selection over outcomes. The data demonstrates that even at 54% market penetration, value-based care has not achieved the cost-control outcomes theoretically expected.
+
 ---
 
 Relevant Notes:

inbox/archive/2025-07-24-kff-medicare-advantage-2025-enrollment-update.md

@@ -7,9 +7,15 @@ date: 2025-07-24
 domain: health
 secondary_domains: []
 format: data
-status: unprocessed
+status: processed
 priority: high
 tags: [medicare-advantage, enrollment, market-concentration, market-share, kff]
+processed_by: vida
+processed_date: 2025-07-24
+claims_extracted: ["medicare-advantage-crossed-majority-enrollment-in-2023-marking-structural-shift-from-traditional-medicare-as-default-program.md", "medicare-advantage-market-is-oligopolistic-with-unitedhealth-and-humana-controlling-46-percent-despite-nominal-plan-choice.md", "chronic-condition-special-needs-plans-grew-71-percent-in-2025-indicating-explosive-demand-for-disease-management-infrastructure.md", "medicare-advantage-overpayment-gap-grew-4-7x-while-enrollment-doubled-showing-scale-worsens-rather-than-improves-efficiency.md"]
+enrichments_applied: ["the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md", "Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening.md", "value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md"]
+extraction_model: "anthropic/claude-sonnet-4.5"
+extraction_notes: "Four new claims extracted covering MA's structural inflection at majority enrollment, market concentration dynamics, C-SNP explosive growth as chronic disease indicator, and the overpayment gap acceleration trajectory. Three enrichments: one challenge to the prevention-first attractor state claim (MA data suggests disease management optimization is the actual attractor), one extension to Devoted growth claim (contextualizing against UHG market consolidation), one confirmation of VBC payment boundary stall (MA overpayment despite nominal value-based structure). Key insight: the spending gap growing 4.7x while enrollment only doubled is the structural smoking gun—scale is making the problem worse, not better."
 ---
 
 ## Content
@@ -79,3 +85,11 @@ tags: [medicare-advantage, enrollment, market-concentration, market-share, kff]
 PRIMARY CONNECTION: [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness]]
 WHY ARCHIVED: Essential market structure data — the enrollment trajectory and concentration metrics ground claims about where the US healthcare system is actually heading vs. where theory says it should go.
 EXTRACTION HINT: The spending gap growing 4.7x while enrollment only doubled is the key structural insight — scale is making the overpayment problem worse, not better.
+
+
+## Key Facts
+- MA enrollment trajectory: 7.6M (19%) in 2007 → 34.1M (54%) in 2025
+- Top 5 MA parent organizations by 2025 enrollment: UnitedHealth 9.9M (29%), Humana 5.7M (17%), CVS/Aetna 4.1M (12%), Elevance 2.2M (7%), Kaiser 2.0M (6%)
+- Plan type distribution 2025: Individual 21.2M (62%), SNPs 7.3M (21%), Employer/union 5.7M (17%)
+- SNP breakdown: D-SNPs 6.1M (83%), C-SNPs 1.2M (16%), I-SNPs 115K (2%)
+- Average beneficiary has 9 plan options; 36% have 10+ options